| Literature DB >> 8831421 |
R G Grifka1, J A Vincent, M R Nihill, F F Ing, C E Mullins.
Abstract
A 2-month-old child with Down syndrome and a large patent ductus arteriosus underwent transcatheter closure using a new Food and Drug Administration-approved occlusion device. This device is described, along with its usefulness for other vascular defects.Entities:
Mesh：
Year: 1996 PMID： 8831421 DOI： 10.1016/s0002-9149(96)00408-0
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778